share_log

12 Health Care Stocks Moving In Monday's After-Market Session

Benzinga ·  Mar 26 05:32

Gainers

  • Stoke Therapeutics (NASDAQ:STOK) shares increased by 77.7% to $11.55 during Monday's after-market session. The company's market cap stands at $515.7 million. As per the news, the Q4 earnings report came out today.
  • OpGen (NASDAQ:OPGN) shares moved upwards by 66.61% to $0.79. The market value of their outstanding shares is at $7.9 million.
  • Universe Pharmaceuticals (NASDAQ:UPC) stock rose 11.62% to $1.92. The company's market cap stands at $7.0 million.
  • Vaxxinity (NASDAQ:VAXX) shares moved upwards by 7.99% to $0.72. The company's market cap stands at $90.8 million.
  • Unity Biotechnology (NASDAQ:UBX) stock rose 7.39% to $1.7. The market value of their outstanding shares is at $28.4 million.
  • Brainstorm Cell (NASDAQ:BCLI) stock increased by 6.87% to $0.7. The market value of their outstanding shares is at $34.2 million.

Losers

  • Agile Therapeutics (NASDAQ:AGRX) shares declined by 54.7% to $0.27 during Monday's after-market session.
  • NeuBase Therapeutics (NASDAQ:NBSE) stock decreased by 54.53% to $0.45. The market value of their outstanding shares is at $1.6 million.
  • Portage Biotech (NASDAQ:PRTG) stock declined by 6.73% to $0.48. The market value of their outstanding shares is at $9.4 million.
  • Omeros (NASDAQ:OMER) shares decreased by 6.69% to $3.21. The company's market cap stands at $201.7 million.
  • BIMI Intl Medical (NASDAQ:BIMI) shares decreased by 6.46% to $1.73. The company's market cap stands at $24.2 million.
  • Regenxbio (NASDAQ:RGNX) stock decreased by 5.15% to $20.48. The company's market cap stands at $1.0 billion.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment